Facilitation of personal recovery among people with mental illness Mental and Behavioural Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18 years or above 2. Permanent Hong Kong residents 3. Diagnosed with mental illness with standardised diagnostic criteria, such as the Classification of Diseases (11th ed.; ICD-11; World Health Organization, 2018) or Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5; American Psychiatric Association, 2013), for any length of illness 4. Capable of providing informed consent to participate in the trial; (v) able to understand Chinese languages to engage in the intervention or to complete written assessment in Chinese; and 5. A service user from the community-based mental health service
Exclusion criteria
Exclusion criteria: 1. Established diagnosis of learning disability or major cognitive impairment arising from any underlying medical condition resulting in significant functional impairment 2. Primary diagnosis of substance abuse, as substance use may increase and/or trigger symptoms of mental illnesses, and hence it has different trajectories from other mental illnesses 3. Mental state that precludes the possibility of engaging in the intervention (e.g. significant thought disorder) 4. Engagement in concurrent mindfulness intervention 5. Do not provide informed consent 6. Refused to be randomised
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Personal recovery: Recovery Assessment Scale (RAS-C) at pre-, post-intervention and 1-month follow-up Trait mindfulness: Kentucky Inventory of Mindfulness Skills (KIMS-17-C), Mindful Attention Awareness Scale (MAAS) at pre-, post-intervention and 1-month follow-up 2. Self-compassion: Self-compassion Scale (SCS) at pre-, post-intervention and 1-month follow-up 3. Resilience: Connor-Davidson Resilience Scale (CD-RISC) at pre-, post-intervention and 1-month follow-up 4. Mindfulness-based intervention participants' experiences and views: Qualitative Interviews at post-intervention and 1-month follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Depression, Stress and Anxiety: The Depression Anxiety Stress Scales (DASS-21) at pre-, post-intervention and 1-month follow-up 2. Positive and negative affect: Positive and Negative Affect Schedule (PANAS) at pre-, post-intervention and 1-month follow-up 3. Quality of life and general health: The World Health Organization Quality of Life – BREF (WHOQOL-BREF) at pre-, post-intervention and 1-month follow-up | — |
Countries
Hong Kong